Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Levy

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
The Journal of Rheumatology|September 17, 2018
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus ErythematosusChristine A Peschken, Yishu Wang, Michal Abrahamowicz, et al.
Arthritis Care & Research|February 7, 2018
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus ErythematosusMichael J Holland, Michael W Beresford, Brian M Feldman, et al.
American Journal of Epidemiology|February 1, 2020
Perspectives on the Future of Epidemiology: A Framework for TrainingBryan Lau, Priya Duggal, Stephan Ehrhardt, et al.
The Journal of Rheumatology|December 3, 2016
Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in CanadaClaire E H Barber, Lauren Jewett, Elizabeth M Badley, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
The Journal of Rheumatology|August 4, 2012
Access to biologic therapies in Canada for children with juvenile idiopathic arthritisClaire M A Leblanc, Bianca Lang, Alma Bencivenga, et al.
Orphanet Journal of Rare Diseases|October 22, 2025
Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administrationKatlyn Elizabeth McGrattan, Alicia Hofelich Mohr, Anna Miles, et al.
Annals of the Rheumatic Diseases|February 26, 2013
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive proteinStacy P Ardoin, Laura Eve Schanberg, Christy I Sandborg, et al.
The Journal of Rheumatology|September 3, 2018
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus ErythematosusStephanie O Keeling, Zainab Alabdurubalnabi, Antonio Avina-Zubieta, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosusJyotsna Bhattacharya, Karalyn Pappas, Bahtiyar Toz, et al.
The Journal of Rheumatology|September 17, 2018
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus ErythematosusChristine A Peschken, Yishu Wang, Michal Abrahamowicz, et al.
Arthritis Care & Research|February 7, 2018
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus ErythematosusMichael J Holland, Michael W Beresford, Brian M Feldman, et al.
American Journal of Epidemiology|February 1, 2020
Perspectives on the Future of Epidemiology: A Framework for TrainingBryan Lau, Priya Duggal, Stephan Ehrhardt, et al.
The Journal of Rheumatology|December 3, 2016
Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in CanadaClaire E H Barber, Lauren Jewett, Elizabeth M Badley, et al.
Annals of the Rheumatic Diseases|July 24, 2020
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trialHermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, et al.
The Journal of Rheumatology|August 4, 2012
Access to biologic therapies in Canada for children with juvenile idiopathic arthritisClaire M A Leblanc, Bianca Lang, Alma Bencivenga, et al.
Orphanet Journal of Rare Diseases|October 22, 2025
Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administrationKatlyn Elizabeth McGrattan, Alicia Hofelich Mohr, Anna Miles, et al.
Annals of the Rheumatic Diseases|February 26, 2013
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive proteinStacy P Ardoin, Laura Eve Schanberg, Christy I Sandborg, et al.
The Journal of Rheumatology|September 3, 2018
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus ErythematosusStephanie O Keeling, Zainab Alabdurubalnabi, Antonio Avina-Zubieta, et al.
Pageof 5